Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Alnylam Pharmaceuticals, Inc. | StockGist | StockGist

Companies
ALNY
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings ALNYSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Alnylam Pharmaceuticals, Inc.

Filed Feb 13, 2025

Accepted Feb 12, 2025, 7:00 PM ET

CIK 0001178670

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

ALNYLAM PHARMACEUTICALS, INC.

Person Type

IA

CUSIP: 02043Q107

Amendment History

3 filings

SCHEDULE 13G
Original
Viewing
Feb 13, 20250001422848-25-000022
SCHEDULE 13G/A
Amendment 1
Apr 7, 20250000932471-25-000378
SCHEDULE 13G/A
Amendment 2
Latest
Mar 26, 20260000102909-26-000562

Recent Filings

Alnylam Pharmaceuticals, Inc.1 weeks ago

Alnylam Pharmaceuticals, Inc.1 months ago

Alnylam Pharmaceuticals, Inc.1 months ago

Alnylam Pharmaceuticals, Inc.1 months ago

Alnylam Pharmaceuticals, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice